Record early stage funding for Oxford projects
Thirty-five Oxford projects received £4.6m in funding from proof-of-concept and seed funds managed by Oxford University Innovation in the last financial year.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Thirty-five Oxford projects received £4.6m in funding from proof-of-concept and seed funds managed by Oxford University Innovation in the last financial year.
Oxford University Innovation spinout NightstaRx Ltd (“Nightstar”), a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, has announced a $35 million Series B financing round.
A £50m fund for investing in UK technology for application in China has been launched as part of Chinese President Xi Jinping’s official trip to the UK. Oxford University Innovation is acting as consultant to the fund.
Oxford spin-out Oxitec Limited has been sold to synthetic biology specialist Intrexon Corporation (NYSE:XON) for $160m. Oxitec is commercialising technology to control pests and invasive species including mosquitos, which spread dengue fever and other diseases.
Oxford Sciences Innovation, which will provide capital and scaling expertise to Oxford spinouts, has now raised £320m from investors including billionaire Charles Dunstone, who launched Carphone Warehouse, and Google Ventures.
UK companies can secure £500K or more in regional government grants via the UK2China Market Expansion Programme. Oxford University Innovation (Hong Kong) announces launch of the pilot UK2China Market Expansion Programme.
Global University Venturing investigates the creation of Oxford Sciences Innovation - the largest single university venturing fund it has yet recorded.
A new company, Oxford Sciences Innovation plc, will provide capital and scaling expertise to businesses driven by intellectual property (IP) developed in Oxford’s Mathematical, Physical, Life Sciences Division and Medical Sciences Divisions.